Maria Kavallaris
#132,338
Most Influential Person Now
Australian cancer researcher
Maria Kavallaris's AcademicInfluence.com Rankings
Maria Kavallarislaw Degrees
Law
#2850
World Rank
#3550
Historical Rank
Jurisprudence
#66
World Rank
#138
Historical Rank
Common Law
#163
World Rank
#176
Historical Rank
International Law
#856
World Rank
#1035
Historical Rank
Download Badge
Law
Why Is Maria Kavallaris Influential?
(Suggest an Edit or Addition)According to Wikipedia, Maria Kavallaris is an Australian scientist, based at the University of New South Wales' Children's Cancer Institute, where she is best known for her contributions to the field of cancer research. On 25 January 2019, Kavallaris was appointed a member of the Order of Australia.
Maria Kavallaris's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. (1997) (600)
- Metronomic chemotherapy: new rationale for new directions (2010) (562)
- Microtubules and resistance to tubulin-binding agents (2010) (562)
- Microtubules and resistance to tubulin-binding agents (2010) (446)
- Movers and shakers: cell cytoskeleton in cancer metastasis (2014) (402)
- Minimum information reporting in bio–nano experimental literature (2018) (380)
- Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells (2000) (331)
- Microtubules and Their Role in Cellular Stress in Cancer (2014) (290)
- Biologically Targeted Magnetic Hyperthermia: Potential and Limitations (2018) (279)
- Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. (2001) (219)
- Class III β-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non–Small Cell Lung Cancer (2007) (198)
- The role of β-tubulin isotypes in resistance to antimitotic drugs (2001) (195)
- Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol (1999) (186)
- Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment (2011) (183)
- Nucleic acid hybridization on an electrically reconfigurable network of gold-coated magnetic nanoparticles enables microRNA detection in blood (2018) (181)
- Microtubules: A dynamic target in cancer therapy (2008) (178)
- Acid-labile core cross-linked micelles for pH-triggered release of antitumor drugs. (2008) (170)
- Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. (2013) (146)
- β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma (2013) (141)
- Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β‐tubulins (2007) (136)
- Integrative analysis of RUNX1 downstream pathways and target genes (2008) (129)
- Role of pancreatic stellate cells in chemoresistance in pancreatic cancer (2014) (127)
- Identification of Glycan Structure Alterations on Cell Membrane Proteins in Desoxyepothilone B Resistant Leukemia Cells* (2011) (119)
- Tissue-specific Tropomyosin Isoform Composition (2005) (118)
- Anticancer therapy with novel tubulin-interacting drugs. (2001) (114)
- Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions. (2003) (114)
- Anti-fouling magnetic nanoparticles for siRNA delivery (2010) (108)
- Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. (2007) (107)
- Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers. (2013) (105)
- Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma. (2003) (103)
- Microtubule alterations and resistance to tubulin-binding agents (review). (2002) (103)
- betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer. (2010) (101)
- Dual Bioresponsive Mesoporous Silica Nanocarrier as an “AND” Logic Gate for Targeted Drug Delivery Cancer Cells (2014) (99)
- Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. (2014) (96)
- Dextran-based doxorubicin nanocarriers with improved tumor penetration. (2014) (95)
- Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin (2010) (94)
- Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study (2016) (92)
- Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers. (2013) (90)
- Proteome Analysis of Vinca Alkaloid Response and Resistance in Acute Lymphoblastic Leukemia Reveals Novel Cytoskeletal Alterations* (2003) (89)
- TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members (2012) (85)
- Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. (1989) (84)
- Involvement of MDR1 P‐glycoprotein in multifactorial resistance to methotrexate (1996) (84)
- Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion (2020) (80)
- An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance (2017) (80)
- The role of beta-tubulin isotypes in resistance to antimitotic drugs. (2001) (79)
- Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia – An in vivo study (2006) (78)
- Nanoparticles for radiooncology: Mission, vision, challenges. (2017) (77)
- Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins. (2007) (77)
- Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells (1999) (75)
- Acid-cleavable polymeric core-shell particles for delivery of hydrophobic drugs. (2006) (74)
- Stimuli-responsive functionalized mesoporous silica nanoparticles for drug release in response to various biological stimuli. (2014) (70)
- Frontiers in the treatment of glioblastoma: Past, present and emerging. (2021) (68)
- A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cells (2006) (64)
- The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance. (1997) (63)
- Alterations in γ-Actin and Tubulin-Targeted Drug Resistance in Childhood Leukemia (2006) (63)
- Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer (2013) (63)
- Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs. (2004) (62)
- Improving the targeting of tubulin-binding agents: lessons from drug resistance studies. (2005) (60)
- Drug delivery: beyond active tumour targeting. (2014) (60)
- Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma. (1997) (60)
- Functionalizing biodegradable dextran scaffolds using living radical polymerization: new versatile nanoparticles for the delivery of therapeutic molecules. (2012) (60)
- RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model (2014) (59)
- TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells (2010) (58)
- γ‐Actin regulates cell migration and modulates the ROCK signaling pathway (2011) (57)
- A photoelectrochemical platform for the capture and release of rare single cells (2018) (57)
- βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer (2014) (57)
- Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity. (2008) (56)
- LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs (2010) (55)
- A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo. (2016) (54)
- Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells (2012) (53)
- Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer (2015) (51)
- TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer. (2015) (51)
- Proteomics and disease: opportunities and challenges (2005) (49)
- TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization (2013) (49)
- ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties (2010) (48)
- Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia. (2020) (43)
- MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors. (1996) (43)
- Markedly diminished drug resistance-inducing properties of vinflunine (20′,20′-difluoro-3′,4′-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro (2001) (38)
- Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia. (2006) (38)
- Potential mechanisms of resistance to microtubule inhibitors. (2008) (38)
- P‐glycoprotein‐mediated methotrexate resistance in CCRF‐CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene (1998) (38)
- Specific β-Tubulin Isotypes Can Functionally Enhance or Diminish Epothilone B Sensitivity in Non-Small Cell Lung Cancer Cells (2011) (37)
- Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. (1993) (36)
- The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro (2011) (36)
- Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth (2016) (35)
- Magnetic catechin–dextran conjugate as targeted therapeutic for pancreatic tumour cells (2014) (34)
- The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation. (2009) (33)
- Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate. (1989) (31)
- Doxorubicin conjugated, crosslinked, PEGylated particles prepared via one-pot thiol-ene modification of a homopolymer scaffold: synthesis and in vitro evaluation (2011) (30)
- Macromolecular Hydrogen Sulfide Donors Trigger Spatiotemporally Confined Changes in Cell Signaling. (2016) (30)
- Manganese-Based Magnetic Layered Double Hydroxide Nanoparticle: A pH-Sensitive and Concurrently Enhanced T1/T2-Weighted Dual-Mode Magnetic Resonance Imaging Contrast Agent. (2019) (30)
- Water Soluble Antioxidant Dextran-Quercetin Conjugate with Potential Anticancer Properties. (2018) (30)
- A 3D Bioprinter Specifically Designed for the High-Throughput Production of Matrix-Embedded Multicellular Spheroids. (2020) (30)
- Stathmin mediates neuroblastoma metastasis in a tubulin-independent manner via RhoA/ROCK signaling and enhanced transendothelial migration (2017) (29)
- The Estrogen-responsive B Box Protein Is a Novel Regulator of the Retinoid Signal* (2006) (28)
- Synthesis, self-assembly and stimuli responsive properties of cholesterol conjugated polymers (2012) (28)
- Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics. (2011) (27)
- Efficient functionalisation of dextran-aldehyde with catechin: potential applications in the treatment of cancer (2016) (25)
- Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma (2018) (25)
- Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation (2020) (24)
- A Role for Altered Microtubule Polymer Levels in Vincristine Resistance of Childhood Acute Lymphoblastic Leukemia Xenografts (2008) (24)
- Gamma-actin is involved in regulating centrosome function and mitotic progression in cancer cells (2015) (24)
- Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction. (1993) (23)
- βIII-Tubulin alters glucose metabolism and stress response signaling to promote cell survival and proliferation in glucose-starved non-small cell lung cancer cells. (2016) (22)
- Polyphenol Conjugates by Immobilized Laccase: The Green Synthesis of Dextran‐Catechin (2016) (22)
- γ-Actin plays a key role in endothelial cell motility and neovessel maintenance (2015) (22)
- Drug resistance mechanisms in cancer cells: a proteomics perspective. (2003) (21)
- The cyclin-dependent kinase inhibitor, p21(WAF1), promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cells. (2009) (21)
- Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells (2017) (21)
- The RhoGAP protein ARHGAP18/SENEX localizes to microtubules and regulates their stability in endothelial cells (2017) (20)
- Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells. (2021) (19)
- Novel functional cisplatin carrier based on carbon nanotubes–quercetin nanohybrid induces synergistic anticancer activity against neuroblastoma in vitro (2014) (19)
- Dicer-labile PEG conjugates for siRNA delivery. (2011) (19)
- Perceptions in health and medical research careers: the Australian Society for Medical Research Workforce Survey (2008) (19)
- Graphene Oxide - Gelatin Nanohybrids as Functional Tools for Enhanced Carboplatin Activity in Neuroblastoma Cells (2015) (19)
- Partial Depletion of Gamma-Actin Suppresses Microtubule Dynamics (2013) (19)
- Cytoskeleton and Human Disease (2012) (18)
- Tuneable catechin functionalisation of carbohydrate polymers. (2017) (18)
- The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs (2016) (17)
- Evolution of Resistance to Aurora Kinase B Inhibitors in Leukaemia Cells (2012) (17)
- The endocytic pathway and therapeutic efficiency of doxorubicin conjugated cholesterol-derived polymers. (2015) (17)
- Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16INK4a during immortalization (2012) (16)
- 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells (2016) (15)
- Choice of Capping Group in Tripeptide Hydrogels Influences Viability in the Three-Dimensional Cell Culture of Tumor Spheroids. (2017) (15)
- Growth inhibitory retinoid effects after recruitment of retinoid X receptor β to the retinoic acid receptor β promoter (2003) (15)
- A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction (2019) (15)
- Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach. (2014) (14)
- Class I β-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions (2008) (14)
- The cytoskeleton as a therapeutic target in childhood acute leukemia: obstacles and opportunities. (2007) (14)
- β-Tubulin carboxy-terminal tails exhibit isotype-specific effects on microtubule dynamics in human gene-edited cells (2018) (13)
- In vivo [64Cu]CuCl2 PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasis (2018) (13)
- Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids12 (2016) (13)
- Thymosin‐β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma (2015) (13)
- Identification of novel medulloblastoma cell-targeting peptides for use in selective chemotherapy drug delivery. (2020) (12)
- Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter. (2003) (12)
- Reduced drug accumulation as the mechanism of extreme clinical resistance to methotrexate in the human T‐cell leukemia xenograft, LALW‐2 (1991) (11)
- Computational analysis of image‐based drug profiling predicts synergistic drug combinations: Applications in triple‐negative breast cancer (2014) (11)
- A Covalently Crosslinked Ink for Multimaterials Drop-on-Demand 3D Bioprinting of 3D Cell Cultures. (2021) (10)
- Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia (2021) (10)
- Karyotypic analysis of CCRF-CEM and drug-resistant cell lines with stable and unstable ploidy. (1993) (9)
- Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells (2017) (9)
- Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine Glioma (2021) (9)
- The RNA‐helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma (2021) (9)
- Association of N‐myc amplification with neuroblastoma: The Australian and New Zealand experience (1992) (9)
- A high-throughput 3D bioprinted cancer cell migration and invasion model with versatile and broad biological applicability (2021) (9)
- N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity (2020) (9)
- β III-Tubulin Is a Multifunctional Protein Involved in Drug Sensitivity and Tumorigenesis in Non – Small Cell Lung Cancer (2010) (9)
- Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma. (2021) (8)
- NANOPARTICLE DELIVERY OF siRNA AS A NOVEL THERAPEUTIC FOR HUMAN DISEASE (2012) (8)
- Modulating the Selectivity and Stealth Properties of Ellipsoidal Polymersomes through a Multivalent Peptide Ligand Display (2020) (8)
- Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapy (2022) (8)
- Aerosol delivery of star polymer-siRNA nanoparticles as a therapeutic strategy to inhibit lung tumor growth. (2022) (7)
- Spatio-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density. (2021) (7)
- A crisis in the making? Education, ageing populations and the future of the medical research workforce (2011) (7)
- When polymers meet carbon nanostructures: expanding horizons in cancer therapy. (2019) (7)
- Analyses of Tumor Burden In Vivo and Metastasis Ex Vivo Using Luciferase-Expressing Cancer Cells in an Orthotopic Mouse Model of Neuroblastoma. (2016) (7)
- Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application (2022) (6)
- Microtubule-Associated Proteins and Microtubule-Interacting Proteins (2008) (6)
- Block Co-polymer Nanoparticles with Degradable Cross-Linked Core and Low-Molecular-Weight PEG Corona for Anti-tumour Drug Delivery (2011) (6)
- Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration. (1990) (6)
- The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models. (2019) (6)
- N-myc gene amplification in neuroblastoma determined by the polymerase chain reaction. (1994) (6)
- Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery. (2013) (6)
- Modeling the Distribution of Diprotic Basic Drugs in Liposomal Systems: Perspectives on Malaria Nanotherapy (2019) (6)
- Reply: Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma' – β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs (2013) (5)
- A pedigree with autosomal dominant thrombocytopenia, red cell macrocytosis, and an occurrence of t(12:21) positive pre-B acute lymphoblastic leukemia. (2007) (5)
- Thiol-Reactive Star Polymers Functionalized with Short Ethoxy-Containing Moieties Exhibit Enhanced Uptake in Acute Lymphoblastic Leukemia Cells (2019) (5)
- Nanotechnology in Medical Research (2017) (5)
- Lgr4-Mediated Potentiation Of Wnt/β-Catenin Signaling Promotes MLL Leukemogenesis Via An Rspo3/Wnt3a-Gnaq Pathway In Leukemic Stem Cells (2013) (5)
- Two-stage incorporation of thymidine triphosphate into mammalian DNA as indicated by chromatography on benzoylated DEAE-cellulose. (1986) (5)
- An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro. (1995) (4)
- Targeting Functional Activity of AKT Has Efficacy against Aggressive Neuroblastoma. (2020) (4)
- A covalently crosslinked bioink for multi-materials drop-on-demand 3D bioprinting of three-dimensional cell cultures (2021) (4)
- βIII-Tubulin Gene Regulation in Health and Disease (2022) (4)
- Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration (2019) (4)
- A potent targeted cancer nanotherapeutic (2019) (4)
- Synthesis, anti-cancer and anti-inflammatory activity of novel 2-substituted isoflavenes. (2014) (4)
- Microtubules : a Moving Target in Cancer Therapy (2007) (3)
- Precise, high-throughput production of multicellular spheroids with a bespoke 3D bioprinter (2020) (3)
- Abstract 5022: Precision medicine: High-throughput 3D bioprinting of embedded multicellular cancer spheroids (2018) (3)
- Microtubules, Drug Resistance, and Tumorigenesis (2012) (3)
- Characterization of Mechanisms Mediating Drug Resistance in Human Leukemic Cells Selected with High Concentration Methotrexate (1991) (3)
- Abstract 3224: Copper homeostasis: A new player in anti-tumor immune response (2019) (2)
- miR-99b-5p, miR-380-3p and miR-485-3p are novel chemosensitising miRNAs in high-risk neuroblastoma. (2022) (2)
- High temporal resolution RNA-seq time course data reveals widespread synchronous activation between mammalian lncRNAs and neighboring protein-coding genes (2022) (2)
- Multi-User Immersive Virtual Reality Prototype for Collaborative Visualization of Microscopy Image Data (2019) (2)
- Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors (2021) (2)
- Monitoring the heterogeneity in single cell responses to drugs using electrochemical impedance and electrochemical noise (2020) (1)
- A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia. (2021) (1)
- Abstract 3431: βIII-tubulin in glioblastoma: An emerging multifactorial survival factor role in chemotherapy response and tumor formation. (2013) (1)
- Application of Rapid Fluorescence Lifetime Imaging Microscopy (RapidFLIM) to Examine Dynamics of Nanoparticle Uptake in Live Cells (2022) (1)
- Visual microscope for massive genomics datasets, expanded perception and interaction (2018) (1)
- Tuning the Mechanical Properties of Multiarm RAFT-Based Block Copolyelectrolyte Hydrogels via Ionic Cross-Linking for 3D Cell Cultures. (2022) (1)
- Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia (2022) (1)
- Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine (2020) (1)
- Metronomic Chemotherapy Regimens Using Microtubule-Targeting Agents: Mechanisms of Action, Preclinical Activity and Future Developments (2014) (1)
- In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells. (1998) (1)
- Two classes of single-stranded regions evident in deproteinized preparations of replicating DNA isolated from mammalian cells. (1991) (1)
- βIII-Tubulin Structural Domains Regulate Mitochondrial Network Architecture in an Isotype-Specific Manner (2022) (1)
- Abstract A156: Mechanisms of resistance to Aurora kinase B inhibitors in leukemia: Development and characterization of in vitro models (2009) (1)
- Concentration- and schedule-dependent effects of chemotherapy on the angiogenic potential and drug sensitivity of vascular endothelial cells (2012) (0)
- Abstract 5484: Structural domains of βIII-Tubulin regulate multiple stress responses and influence cell growth and survival in glucose-deprived non-small cell lung cancer (2017) (0)
- Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells (2017) (0)
- Abstract 3435: Targeting AKT activity inhibits MYCN and sensitizes neuroblastoma to chemotherapeutic agents (2019) (0)
- The role of the estrogen-responsive B box protein (EBBP) in cancer cell cycle progression (2008) (0)
- 326 Repression of Essential Telomerase Components Mediates Anti-proliferative Effects in Isogenic Immortal and Tumorigenic Cells, but not Normal Cells (2012) (0)
- Synthesis of glucosylated N-glycans using transglycosylation activity of Golgi endo-α-mannosidase ” (2014) (0)
- Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma. (2023) (0)
- A potent targeted cancer nanotherapeutic (2019) (0)
- Alkaloids Independent of P-Glycoprotein Vinca Resistance to Drug-resistant Human Leukemia Cell Line ( LALW-2 ) : Atypical Multidrug Resistance in a Therapy-induced Updated (1989) (0)
- Therapeutics , Targets , and Chemical Biology Cancer Research β III-Tubulin Is a Multifunctional Protein Involved in Drug Sensitivity and Tumorigenesis in Non – Small Cell Lung Cancer (2010) (0)
- How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells? (2022) (0)
- DDEL-12. NANOPARTICLE DELIVERY OF DOXORUBICIN FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2020) (0)
- 182 POSTER Differential proteomic analysis of low-level anti-microtubule resistance in acute lymphoblastic leukaemia (2006) (0)
- 525 Functional characterisation of beta-tubulin mutations: Insights into paclitaxel/tubulin interactions (2004) (0)
- Editorial [Hot Topic: Tubulin/Microtubule System as an Anti-Cancer Drug Target (Guest Editor: A/Prof. Maria Kavallaris Ph.D.) ] (2007) (0)
- Abstract 1442: Identifying the molecular basis by which βIII-tubulin promotes tumor cell survival and drug resistance in non-small cell lung cancer (2020) (0)
- Abstract LB-368: III-tubulin knockdown in endothelial cells increases the antivascular activity of chemotherapeutic drugs (2010) (0)
- Abstract 5026: βIII-Tubulin regulates expression of proteins involved in tumorigenesis and metastasis in non-small cell lung cancer (2010) (0)
- A Novel Engineered Single-Chain Antibody Fragment for Targeting Pediatric Philadelphia Chromosome-like Acute Lymphoblastic Leukemia (2020) (0)
- Abstract 730: Identifying the mechanisms of action and resistance to the novel multi-kinase inhibitor ENMD-2076 in leukemia (2011) (0)
- ENMD-1198 in Combination with Vincristine Shows Synergistic Activity in Leukemia Cells and Prolonged Mouse Survival in Human Leukemia Xenografts. (2007) (0)
- Electrostatic Assembly of Multiarm PEG-Based Hydrogels as Extracellular Matrix Mimics: Cell Response in the Presence and Absence of RGD Cell Adhesive Ligands. (2023) (0)
- Design of anti-fouling and no-cytotoxic magnetic nanoparticles for siRNA delivery (2011) (0)
- PO-354 Star-shaped gene silencing nanoparticles– an advanced approach to treating medulloblastoma (2018) (0)
- TUBB 3 / b III-Tubulin Acts through the PTEN / AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non – Small Cell Lung Cancer (2015) (0)
- Sensitivity Alkaloid Vinca-Tubulin in β Class II and Class IVb Tubulin-Targeted Drug Action : Functional Significance of Updated (2008) (0)
- Correction to "effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers". (2015) (0)
- Abstract 2076: βIII-tubulin is required for the tumorigenic phenotype and resistance to anoikis via the PTEN/AKT signaling axis in non-small cell lung cancer (2014) (0)
- Abstract 326: βIII-Tubulin and cell survival: Novel role in endoplasmic reticulum stress and autophagy in non-small cell lung cancer (2014) (0)
- Abstract 3660: Discovery of a small molecule TUBB3/βIII-tubulin modulator in lung cancer (2015) (0)
- Harnessing copper in cancer to enhance anti-tumor immune response (2018) (0)
- Abstract 1969: Silencing αIII-tubulin by RNA interfering nanoparticles in non-small cell lung cancer (2012) (0)
- Abstract 4037: High throughput kinase inhibitor screen reveals novel inhibitor combinations acting in synergy withTUBB3/βIII-tubulin suppression in non-small cell lung cancer (2017) (0)
- Abstract 1340: Dextran-Catechin conjugate: An anticancer nano-modified natural compound targeting copper metabolism in neuroblastoma (2016) (0)
- Tropomyosin antibodies identify functionally distinct populations of actin filaments (2004) (0)
- Graphene Oxide - Gelatin Nanohybrids as Functional Tools for Enhanced Carboplatin Activity in Neuroblastoma Cells (2014) (0)
- Membrane glycome is impacted by the cell culturing mode of neuroblastoma cells with differing migration and invasion potential. (2022) (0)
- Spatial-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density (2021) (0)
- βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells (2022) (0)
- Discovering novel strategies for antimicrotubule cytotoxic therapy (2006) (0)
- Efficacy of epothilone B in non-small cell lung cancer cells: Role of beta-tubulin isotypes (2008) (0)
- Abstract 5141: Stathmin mediates neuroblastoma migration and invasion via regulation of the actin network (2010) (0)
- Abstract 2555: Drug repositioning: Propanolol potentiates the anticancer efficacy of chemotherapeutic agents through modulation of angiogenesis (2011) (0)
- 527 ILX651 inhibits polymerization of alpha beta III tubulin and is cytotoxic to beta tubulin mutant tumor cell lines that overexpress beta III tubulin (2004) (0)
- 217: The identification of novel targets in β-catenin-driven acute myeloid leukemic stem cells (2014) (0)
- Abstract 1110: Molecular and functional alterations associated with repression of tumor suppressor p16INK4a during immortalization of human endothelial cells (2010) (0)
- High temporal resolution RNA-seq time course data reveals mammalian lncRNA activation mirrors neighbouring protein-coding genes (2021) (0)
- Abstract 4987: Stathmin regulates cell migration, invasion and transendothelial migration via RhoA activation in neuroblastoma (2014) (0)
- SHOWCASE ON RESEARCH Choreography of the Mammalian Cytoskeleton (2009) (0)
- Abstract 1444: Stathmin suppression influences ROCK signaling and reduces cell invasion and metastasis in neuroblastoma (2012) (0)
- Abstract 4418: ENMD-1198, a new microtubule-targeting agent with potent anti-vascular properties (2010) (0)
- What is nanomedicine, and how can it improve childhood cancer treatment? (2020) (0)
- A photoelectrochemical platform for the capture and release of rare single cells (2018) (0)
- Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration (2019) (0)
- Targeting RSPO3-LGR4Sig naling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia (2020) (0)
- Abstract P143: Development of siRNA-loaded lipid nanoparticles targeting long non-coding RNA LINC01257 as a novel and safe therapeutic approach for paediatric acute myeloid leukaemia (2021) (0)
- A 3D bioprintable hydrogel with tuneable stiffness for exploring cells encapsulated in matrices of differing stiffnesses (2022) (0)
This paper list is powered by the following services:
Other Resources About Maria Kavallaris
What Schools Are Affiliated With Maria Kavallaris?
Maria Kavallaris is affiliated with the following schools:
